Cromolyn binding protein in highly purifed form, and methods for the isolation thereof

• US 4,996,296 A
• Filed: 07/27/1987
• Issued: 02/26/1991
• Est. Priority Date: 07/27/1983
• Status: Expired due to Fees

• Current Assignee: Yeda Research and Development Co. Ltd. (Weizmann Institute of Science)
• Original Assignee: Yeda Research and Development Co. Ltd. (Weizmann Institute of Science)
• Inventors: Hemmerich, Stefan, Pecht, Israel
• Primary Examiner(s): Draper, Garnette
• Assistant Examiner(s): Kushan, Jeff
• Application Number:
  US07/078,134
• Time in Patent Office: 1,310 Days
• Field of Search: 530/350, 530/387, 530/380, 530/395, 530/400, 530/4
• US Class Current: 530/350
• CPC Class Codes: C07K 14/705 Receptors; Cell surface antigens; Cell surface determinants tumour specific antigens C07K14/4748
• CPC Class Codes: C07K 16/28 against receptors, cell surface antigens or cell surface determinants
• CPC Class Codes: Y10S 530/802 Chromogenic or luminescent peptides
• CPC Class Codes: Y10S 530/83 Plasma; serum

Abstract

Substantially pure cromolyn binding protein is prepared by means of affinity chromatography of cromolyn derivatives bound to insoluble matrices. Aminocromolyn is prepared by a six-step synthesis and amine derivatives thereof are prepared by conventional means. Obtaining a compound having an amine group instead of the OH group at the 2-carbon of the propane link of cromolyn permits many kinds of reactions without interfering with the portion of the cromolyn molecule with causes its pharmacological activity. The cromolyn derivatives can be conjugated to proteins such as BSA by means of glutaraldehyde cross-linking and such conjugates can be covalently bound to agarose beads. Cromolyn binding protein can be isolated by passing lysates of RBL-2H3 cells through chromatographic columns packed with such beads. The cromolyn binding protein can be further purified by means of lectin-agarose columns.

Claims

1. A method of purifying cromolyn binding protein, comprising:

preparing a chromatography column packed with an insoluble matrix having bound thereto a cromolyn derivative of the general formula ##STR3## wherein R is hydrogen or C_1-5 alkyl and X is amino or an amino derivative;

lysing cells in which cromolyn binding protein is naturally occurring or solubilizing the plasma membrane of said cells;

separating any cromolyn binding protein contained in said lysed cells or solubilized membranes from the non-desired contaminants by passing said lysed cells or solubilized membranes through said column, whereby any cromolyn binding protein is retained on the column while non-desired contaminants pass through; and

eluting the cromolyn binding protein bound to said immobilized cromolyn derivative.

2. A method in accordance with claim 1 and further including the step of further purifying the cromolyn binding protein eluted from said column by subjecting said eluate to SDS-polyacrylamide gel electrophoresis.

3. A method in accordance with claim 1 and further including the step of further purifying the cromolyn binding protein eluted from said column by incubating said eluate on a lectin-agarose conjugate and eluting the cromolyn binding protein which binds to said conjugate.

4. A method in accordance with claim 3 wherein said lectin is wheat germ agglutinin or concanavalin A.

7. The essentially pure protein consisting essentially of cromolyn binding protein produced by the process of claim 1, which, in intact unreduced form, is glycosylated and has an apparent molecular mass of 100,000 as determined by SDS-polyacrylamide gel electrophoresis analysis.

8. The essentially pure protein consisting essentially of cromolyn binding protein produced by the process of claim 2, which, in intact unreduced form is glycosylated and has an apparent molecular mass of 110,000 as determined by SDS-polyacrylamide gel electrophoresis analysis.

9. The essentially pure protein consisting essentially of cromolyn binding protein produced by the process of claim 3, which, in intact unreduced form, is glycosylated and has an apparent molecular mass of 110,000 as determined by SDS-polyacrylamide gel electrophoresis analysis.

10. The essentially pure protein consisting essentially of cromolyn binding protein produced by the process of claim 4, which, in intact unreduced form, is glycosylated and has an apparent molecular mass of 110,000 as determined by SDS-polyacrylamide gel electrophoresis analysis.

5. An essentially pure protein consisting essentially of cromolyn binding protein in intact, unreduced form, said protein being glycosylated and having an apparent molecular mass of 110,000 as determined by SDS-polyacrylamide gel electrophoresis analysis, and wherein the reduced form of said protein has the following amino acid composition:

space="preserve" listing-type="tabular">______________________________________ Amino Acid % w/w % mol/mol ______________________________________ Asp 9.32 8.78 Thr 4.20 4.53 Ser 5.99 7.43 Glu 15.37 12.89 Gly 6.17 11.71 Ala 5.31 8.08 Val 8.40 9.19 Met 0.99 0.78 Ile 6.23 5.96 Leu 7.47 7.15 Tyr 1.85 1.24 Phe 3.89 2.86 His 7.96 6.28 Lys 8.95 7.78 Arg 8.02 5.57. ______________________________________

6. An essentially pure protein consisting essentially of cromolyn binding protein in reduced form, said protein being glycosylated, having an apparent molecular mass of 50,000 as determined by SDS-polyacrylamide gel electrophoresis analysis, and having the following amino acid composition:

space="preserve" listing-type="tabular">______________________________________ Amino Acid % w/w % mol/mol ______________________________________ Asp 9.32 8.78 Thr 4.20 4.53 Ser 5.99 7.43 Glu 15.37 12.89 Gly 6.17 11.71 Ala 5.31 8.08 Val 8.40 9.19 Met 0.99 0.78 Ile 6.23 5.96 Leu 7.47 7.15 Tyr 1.85 1.24 Phe 3.89 2.86 His 7.96 6.28 Lys 8.95 7.78 Arg 8.02 5.57. ______________________________________